Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Amarantus BioScience Holdings, Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, r00kie, joboggi, Sir Francelote, zoomboom, Rosym
Search This Board:
Last Post: 9/30/2014 1:41:37 PM - Followers: 719 - Board type: Free - Posts Today: 14

   

Amarantus BioScience Holdings, Inc.

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensed Eltoprazine, a Phase 2B ready Parkinsons Levadopa induced Dyskinesia. The company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's Disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property rights for the diagnosis of Parkinson's Disease ("NuroPro") and the discovery of neurotrophic facotrs ("PhenoGuard"). For further information, please visit www.Amarantus.comor connect with the company on FacebookTwitter, LinkedIn & Google+



            

 
PRESS RELEASES & NEWS ARTICLES

Amarantus Requests Pre-IND Feedback From FDA for Eltoprazine Phase IIb Parkinson's Disease Levodopa-Induced Dyskinesia Clinical Trial
Sept 29, 2014     2:04 p.m.
Amarantus Shareholders Approve All Matters Voted Upon at Annual Shareholders Meeting
Sept 25, 2014     4:00 p.m.
Amarantus on road to commercializing AD test
September 23, 2014
Fundamental Milestones Ahead: Up-Listing from Strength
Thrursday, Sept. 18th 2014   12:30 p.m.
Amarantus Provides Program Update on Phase 2b Eltoprazine for Parkinson's Disease and Adult ADHD
Sept 17, 2014    8:00 a.m.
Amarantus Completes Enrollment of 72 Patient LP-002 Clinical Study for Alzheimer's Blood Diagnostic LymPro Test(R)
Sept 12, 2014   10:30 a.m.
Amarantus to Present Orphan Ocular Data at Targeting Ocular Disorders Conference 2014
Sept 10, 2014   1:00 p.m.
Amarantus Announces Positive MANF Ocular Toxicology Data
Sept. 9, 2014   8:31 a.m.
Amarantus to Present at Sachs Associates 14th Annual Biotech in Europe Forum for Global Partnering and Investment

Sept 4, 2014   9:00 a.m.
Initiating Studies for CLIA Launch at Icon Central Laboratories
September 2nd, 2014   8:00 am
Amarantus BioScience Holdings, Inc. - "Initiating Studies for CLIA Launch at Icon Central Laboratories"
Sept 2, 2014   8:26 a.m.
Amarantus Initiates CLIA Development of Alzheimer's Blood Diagnostic LymPro Test(R) at ICON Central Laboratories
Sept 2, 2014   6:00 a.m. 
Amarantus Appoints Iain Ross to Board of Directors
Aug. 29, 2014   7:57 a.m. 
Amarantus Reports Second Quarter 2014 Financial Results, Announces Business Update Call
Aug. 27, 2014   9:00 a.m  
Amarantus to Present at Upcoming Investor Conferences
Aug. 19, 2014   8:42 A.M. 

      

 
 
 SNNLive - Amarantus  BioScience Holdings, Inc.
  Published on June 21, 2014
 
SNNLive - Amarantus BioScience Holdings, Inc.
Published on May 21, 2014

 

                                                                   

Medical Dictionary (some often-used terms in AMBS PRs)

The substania nigra is an area of pigmented cells in the midbrain which is responsible for producing the neurotransmitter dopamine. This section of the brain plays an important role in the control of movement, and it also appears to interact in the process of addiction, as well. If you view a brain in cross-section, the substantia nigra is located in the midbrain, right at the tip of the brainstem.
The striatum is also called the striate body. It includes the caudate nucleus and the lentiform nucleus. The term striatum (striate) refers to the layered appearance of bands of gray matter that course from one of these nuclei to the other and represent the connections between them.
In living tissues, reinnervation describes the process by which post-synaptic neurons form new synapses or increase existing synaptic efficacy in order to compensate for a lack of pre-synaptic input from dead or otherwise dysfunctional pre-synaptic neurons.

Glial cell-derived neurotrophic factor, also known as GDNF is a protein that, in humans, is encoded by the GDNF gene.[1] GDNF is a small protein that potently promotes the survival of many types of neurons.[2
Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack


 

  Pertinent Terms of Service
 

A. Is unlawful, threatening, abusive, harassing, defamatory, libelous, vulgar, hateful, deceptive, fraudulent, invasive of another's privacy, tortious, contains explicit or graphic descriptions or accounts of sexual acts (including but not limited to sexual language of a violent or threatening nature directed at another individual or group of individuals), or otherwise violates our rules or policies; This includes signatures as well. 
B. Attacks, verbally or otherwise, any other user, the website, any non-public figure, or any agents or employees of iHub; This includes signatures as well.
C. Victimizes, harasses, degrades, or intimidates an individual or group of individuals on the basis of religion, gender, sexual orientation, race, ethnicity, age, or disability; This includes signatures as well.

 A reminder, if your post is removed and you think it should be restored go to mailbox, and then click on removed posts, and follow the directions. Post that talk about other members, or other companies violate the TOS. Those posts are routinely deleted. It is easy to talk about AMBS without talking about the posters or in most cases, other companies and products.



 
 

      Mr. Commissiong made a presentation on Sept. 12/14 at the Aegis Capital 2014                          Healthcare and Technology Conference at web cast live at 10:00 AM PT and
               available at http://wsw.com/webcast/aegis/ambs/ .
 
  

 

 

blush  AMBS corporate presentation at the Sachs conference in Basel has been moved up to 2pm local time / 8am ET on 9/30/14

   Amarantus Bioscience Holdings, Inc. (otcqb:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic interventions for Alzheimer's disease, Parkinson's disease and
orphan ophthalmological disorders, announced that Gerald E. Commissiong, President and CEO, is scheduled
to present at the 14th Annual Biotech in Europe Forum at the Congress Center in Basel, Switzerland.  
 heart
The presentation is scheduled for  TODAY -  at 2 p.m. local time on 9/30/14 in the Darwin Room.heart  Mr. Commissiong's presentation will be web cast live and available on the company's web site at www.amarantus.com.

Additional information about the conference may be found at www.sachsforum.com. Attendees who wish to meet with management one on one may contact our Investor Relations department at ir@amarantus.com

angel  Dr. Roman Urfer, Chief Development Officer at NeuroAssets Sarl, will be presenting efficacy data for MANF in an undisclosed orphan ocular indication at Targeting Ocular Disorders 2014NeuroAssets is a Swiss-based neuroscience-focused consulting firm engaged by Amarantus to support the translational development of MANF. 
Dr. Urfer's presentation will be made at 3:40pm ET on October 6th, 2014 at the Westin Boston Waterfront Market in Boston, MA.




 
 
    
       

 

Company Information

Investor Relations

Transfer Agent

Amarantus BioScience Holdings, Inc.
c/o Janssen Labs @ QB3
953 Indiana Street
San Francisco, CA 94107

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland

info@amarantus.com
pr@amarantus.com


Phone: (408) 737-2734
Fax: (408) 852-4427

Aimee Boutcher
Director of Investor Relations
Amarantus BioScience Holdings, Inc
.

408-737-2734 x101
ir@amarantus.com







 
VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516

Attn: Allison Niccols


Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179

           
info@vstocktransfer.com

www.VStockTransfer.com 


 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
Wiki
AMBS News: Current Report Filing (8-k) 09/24/2014 04:06:33 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 09/19/2014 04:15:04 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 09/15/2014 05:00:14 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 09/04/2014 06:56:01 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 09/04/2014 04:07:28 PM
PostSubject
#108674  Sticky Note Update from ASM Meeting: Sir Francelote 09/23/14 08:44:23 AM
#108640  Sticky Note Bascom Palmer Licenses Retinal Disorder Product to Biotech Rosym 09/21/14 06:49:48 PM
#108320  Sticky Note New or Potential investors in AMBS r00kie 09/08/14 04:02:27 PM
#104968  Sticky Note MJFF is firm with their notion that NFs joboggi 07/17/14 02:01:07 AM
#108876   Any invention from collaboration AMBS has 1st option. zoomboom 09/30/14 01:41:37 PM
#108875   I received another question regarding my blog of zoomboom 09/30/14 01:40:53 PM
#108874   Read my stickie. It is complicated. And yes, joboggi 09/30/14 01:22:59 PM
#108873   You have said all along you believed in brharris 09/30/14 01:18:05 PM
#108872   and while MANF will continue to be researched joboggi 09/30/14 01:06:33 PM
#108870   they were not able to produce the specific joboggi 09/30/14 11:54:58 AM
#108868   Amarantus Bioscience Holdings, Inc. (otcqb:AMBS), a biotechnology company Rosym 09/30/14 09:57:02 AM
#108867   AMBS corporate presentation at the Sachs conference in Rosym 09/30/14 09:27:51 AM
#108862   Zoom, congrats on your appointment as one of the gipper 09/29/14 10:31:41 PM
#108860   I am waiting for the specific passage. Take joboggi 09/29/14 09:24:09 PM
#108856   I say that it is not there, in joboggi 09/29/14 08:21:46 PM
#108851   calpain is not new by any means. so joboggi 09/29/14 08:10:53 PM
#108850   nice chart... thanks for the AMBS Chart post zoomboom 09/29/14 08:08:36 PM
#108848   I've read the 8k. If you want to joboggi 09/29/14 08:01:00 PM
#108847   Weekly 10, 50 & 200 DMA - Convergence JPetroInc 09/29/14 08:00:17 PM
#108844   takes 2 seconds.. zoomboom 09/29/14 07:30:48 PM
#108843   and where is the email? You said you joboggi 09/29/14 07:22:32 PM
#108842   i did ... i stand by my comment zoomboom 09/29/14 07:19:25 PM
#108841   Note that it is October. ( essentially ) joboggi 09/29/14 06:59:36 PM
#108840   This is extremely unlikely. It would take a joboggi 09/29/14 06:58:20 PM
#108839   LP002 expected next week: https://twitter.com/amarantusbio/status/51671277857318 mstrike 09/29/14 06:19:28 PM
#108838   Amarantus Requests Pre-IND Feedback From FDA for Eltoprazine Rosym 09/29/14 05:44:56 PM
#108837   Good point 68-Tele 09/29/14 04:46:58 PM
#108836   I would encourage you to write to the joboggi 09/29/14 04:23:01 PM
#108834   about 200 million shares, more or less. That joboggi 09/29/14 03:41:25 PM
#108833   The company only owns MANF. The other compounds joboggi 09/29/14 03:39:28 PM
#108831   News!!!! Stock down, what do know tigerlil 09/29/14 03:13:58 PM
#108830   Same as it was in 2012 zoomboom 09/29/14 03:12:25 PM
#108829   What was the OS structure back in 2012 Angry Goat 09/29/14 03:03:31 PM
#108828   It can surpass that. But on AMBS's zoomboom 09/29/14 02:51:42 PM
#108827   Well, they have enough money if they convert joboggi 09/29/14 02:49:06 PM
#108826   I did not read Fumi's post, but I joboggi 09/29/14 02:46:11 PM
#108825   You think this stock can hit the .25 XYREUS 09/29/14 02:42:38 PM
#108824   Yeah. You missed it. 2000% increase zoomboom 09/29/14 02:40:01 PM
#108823   I dunno bout that. I just checked the XYREUS 09/29/14 02:33:49 PM
#108822   It would be the 3rd or 4th monster zoomboom 09/29/14 02:24:32 PM
#108821   Slow moving stock! Very frustrating!!! I have kept XYREUS 09/29/14 02:02:39 PM
#108820   http://ir.amarantus.com/all-sec-filings/content/0001144204-14-039366/0001144204- zoomboom 09/29/14 02:02:15 PM
#108819   I hope so, I'm sure they covered all hnbadger1 09/29/14 01:57:56 PM
#108818   Collaboration probably has a clause. AMBS will zoomboom 09/29/14 01:55:05 PM
#108817   Most definitely not. And I predicted this. I joboggi 09/29/14 01:43:51 PM
#108815   Probably not imo 68-Tele 09/29/14 08:06:45 AM
#108814   Question about AMBS's license with Dr. Urano for hnbadger1 09/29/14 07:42:00 AM
#108813   Looking really good for MANF! Rosym 09/28/14 06:30:16 PM
#108812   http://wolframsyndrome.blogspot.com/2014/09/soluble-factors-for-regenerative.htm 68-Tele 09/28/14 04:25:02 PM
#108811   Aye Ambs shamalam 09/27/14 01:11:32 PM
#108809   Welcome Zoomboom - new MOD JPetroInc 09/27/14 07:36:48 AM
#108805   ++1000 a surfer 09/26/14 09:14:00 PM
#108804   Thanks. I will always try to zoomboom 09/26/14 08:58:38 PM
#108803   The price is currently being supported by the Solantey 09/26/14 08:15:22 PM
PostSubject